These data support the hypothesis that the variable prevalence of unmethylated and partially methylated FXN epialleles (0–64% methylation) underlies the potential for FXN reactivation via HDACi-109 treatment in FRDA. This evidence concerns the gene FXN and Friedreich ataxia.